Clinical trials testing out a new heart failure treatment have stopped because the results are so promising, scientists say.
Researchers are conducting a study into the effects of a new drug aimed at reducing the risk of cardiovascular death and the number of people hospitalised due to heart failure.
The study, which looked at more than 8,400 patients, compared the effectiveness of the new drug LCZ696 against the ACE inhibiter Enalapril.
It was due to finish in October but was stopped early after tests showed the new treatment was producing significantly positive results.
We are delighted at the findings of this study which show a promising way forward for heart failure sufferers
Thembi Nkala, Senior Cardiac Nurse at the British Heart Foundation, said: “We are delighted at the findings of this study which show a promising way forward for heart failure sufferers.
“This reflects on-going rigorous efforts in the fight against this progressive and potentially disabling condition.
“It’s essential though that we patiently await the full completion of this study before the treatment is considered for use by the general public.
“Those affected should continue with their treatment plan as per their doctor’s advice. Stopping smoking, reducing alcohol intake, managing fluid intake and keeping active are amongst the best ways of managing your heart failure better.”